HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
SDGR
Schrödinger, Inc.
SDGR lost money over the past year, so it has no meaningful PE right now.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
SDGR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Weak | |
| Unavailable |
SDGR's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
SDGR PE Valuation
SDGR has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
SDGR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect SDGR's profitability to improve, with its earnings and revenue holding steady. However, they disagree widely on these estimates.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
SDGR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.78 | +$1.63 |
| Q2 2026 | -$0.73 | +$1.75 |
| Q1 2026 | -$1.40 | +$1.23 |
| Q4 2025 | -$1.41 | +$1.16 |
| Q3 2025 | -$2.41 | +$0.02 |
| Q2 2025 | -$2.48 | +$0.29 |
| Q1 2025 | -$2.63 | -$0.66 |
| Q4 2024 | -$2.57 | -576% |
SDGR has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over SDGR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over SDGR on profitability, with a higher operating margin.
SDGR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.5M | +19% |
| Q2 2026 | $58.9M | +7.5% |
| Q1 2026 | $58.6M | -1.6% |
| Q4 2025 | $87.2M | -1.2% |
| Q3 2025 | $54.3M | +54% |
| Q2 2025 | $54.8M | +16% |
| Q1 2025 | $59.6M | +63% |
| Q4 2024 | $88.3M | +19% |
SDGR's revenue is recovering but still below its 2024 peak: $64M last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +44 points |
| Q2 2026 | -71% | +26 points |
| Q1 2026 | -83% | +2.2 points |
| Q4 2025 | -20% | +3.8 points |
| Q3 2025 | -85% | +109 points |
| Q2 2025 | -97% | +15 points |
| Q1 2025 | -85% | +99 points |
| Q4 2024 | -23% | +17 points |
SDGR's operating margin was −41% last quarter, up 44 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over SDGR on cash generation, producing positive trailing cash flow while its opponent burns cash.
SDGR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$48.9M | +$13.5M |
| Q2 2026 | -$34.4M | +$18.1M |
| Q1 2026 | -$17.3M | -112% |
| Q4 2025 | -$16.1M | +$15.9M |
| Q3 2025 | -$62.4M | -$27.8M |
| Q2 2025 | -$52.5M | +$2.2M |
| Q1 2025 | $143.5M | +$186.8M |
| Q4 2024 | -$32M | +$7.7M |
SDGR has burned cash in almost every quarter: −$117M over the past year, against −$3M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over SDGR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
SDGR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -904K shares |
| 1 year | +1.7% | +1.3M shares |
| 3 years | +4.1% | +2.9M shares |
| 5 years | +5.8% | +4.1M shares |
| Available history | +54% | +26.4M shares |
SDGR has 75M diluted shares, up 1.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
SDGR Net Leverage
SDGR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
SDGR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.5 | Neutral |
| Stochastic | 75.2 | Neutral |
SDGR's weekly RSI is 69 (neutral) and its Stochastic is 75 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
SDGR PE vs Healthcare Sector
| Metric | SDGR | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
SDGR has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
SDGR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.6 | 12% above |
| 20 week MA | $22.1 | 39% above |
| 50 week MA | $17.4 | 77% above |
| 100 week MA | $19.3 | 60% above |
| 200 week MA | $23.4 | 32% above |
SDGR has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
SDGR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $31.9 | $84.0 | +163% |
| 2021 | $84.0 | $35.9 | -57% |
| 2022 | $35.9 | $18.9 | -47% |
| 2023 | $18.9 | $35.8 | +90% |
| 2024 | $35.8 | $19.8 | -45% |
| 2025 | $19.8 | $18.3 | -7.4% |
| 2026 YTD | $18.3 | $30.9 | +68% |
SDGR has the edge over HIMS on returns for 2026, with the stronger performance.